Pharma Patient Access

Track Patient Adherence

Even once the patient initiates therapy, adherence is hardly guaranteed. Ongoing payer issues, out-of-pocket costs, and side effects are a few of the factors that complicate the patient journey.

In fact, the National Institute of Health data shows that adherence rates for most medications for chronic conditions such as diabetes and hypertension usually fall in the 50% to 60% range, even with patients who have good insurance and drug benefits. To combat this, pharmaceutical manufacturers often throw money into an array of patient services programs, but without accurate patient status and dispensing data, these programs can be a huge investment with little return.

Drug manufacturers can develop effective patient adherence solutions by:

• Having access to quality patient status data that is readily available
• Collaborating across channels to accurately measure the impact of pharma to patient access service programs on patient adherence
• Quickly and correctly identifying friction points between pharmacies and patient services

Every specialty pharmaceutical manufacturer needs answers to a common set of critical business questions around patient initiation and patient adherence:

• Has the patient started therapy?
• Does the patient understand how to properly administer the drug?
• Did the patient encounter issues with prior authorization requirements?
• Is the patient unable to afford the treatment?
• Did the patient refill the prescription as planned, or have they discontinued therapy?
• Has patient outreach and support been performed per the contract?

Unfortunately, manufacturers often realize each specialty pharmacy has its own ways of calculating metrics and statuses. They also frequently uncover:

• Missing patient status updates
• Missing payer data
• Confusing or out-of-sequence patient status reports
• Issues with patient data mastering